If you have been following my work, you know about the H7N9 infection circulating in Wuhan in 2020. If you missed the memo, this is yet another Fauci-funded bioweapon. Independent researcher John Cullen and I got into it during one of my latest episodes of Truth Lives Here, where he explained how veterinarian Yoshihiro Kawaoka cretaed a gain-of-function H7N9 virus, meaning he experimentally manipulated it — except nobody talks about that.
After a sharp decrease in highly pathogenic avian influenza A virus (H7N9) in mainland China in 2018, highly pathogenic H7N9 viruses re-emerged in 2019. All H7N9 viruses had four continuous essential amino acids at cleavage sites (i.e., KRKRTAR/G and KRKRIAR/G), suggesting high pathogenicity. So, according to very few, the “real” virus in China was the H7N9 virus infection.
Searching for H7N9
But you’d never know it, because it is hard to find. Keep in mind that you’re up against stiff competition regarding the current results ranking for the H7N9 Virus keyword. The competition is mostly national or international governmental health organizations.
- H7N9 virus
-
- human infections
- avian influenza viruses
- Disease Control
- et al
- H7N9 infection
-
- World Health Organization
- human cases
- Mainland China
-
- Hong Kong
- virus has
- H7N9 influenza
- avian influenza A virus
- live-bird
- respiratory tract
- human-to-human transmission
- Advanced Search
- live poultry markets
- United States
- H7N9 virus infection
- risk factor
- Google Scholar
- close contacts
- pandemic potential
- amino acid
- risk assessment
- influenza pandemic
- avian H7N9
- low pathogenic avian influenza
- laboratory-confirmed cases
- respiratory disease
- novel influenza
- severe disease
- known as
- cleavage site
- University of Hong Kong
- virus strains
- Emerg Infect Dis
- H7N9 avian influenza
- poultry exposure
- avian flu
- neuraminidase inhibitor
- influenza virus infection
- acute respiratory distress syndrome
- bird markets
- live bird markets
- antiviral drugs
- Emerging Infectious Diseases
- host cells
- human population
- influenza infection
- virus replication
- influenza vaccine
- Fact sheets
- epidemic waves
- Animal Health
- Global Health
- Disease Outbreak News
- highly pathogenic avian influenza A
- United Kingdom
- phylogenetic trees
- National Center
- epithelial cells
- severe pneumonia
- avian species
- N Engl J Med
- human beings
- Chen Y
- candidate vaccine viruses
- respiratory infection
- sialic acid receptors
- virus subtype
- health authorities
- matrix protein
- Open access
- Scale bars
- HPAI A
- eastern China
- Human Health
- influenza A subtype
- systematic review
- International Health Regulations
- cases of human infection
- genome sequencing
- serum samples
- wild birds
- Infected poultry
- phylogenetic analysis
- human disease
- previous reports
- Asian lineage
- influenza-like illness
- Ministry of Agriculture
- new virus
- infected birds
- high fever
- viral proteins
- immune responses
- Southeast Asia
Is The Avian Flu A Smokescreen?
In Plain Sight!
I read headlines about the latest infected birds, cows, and wild infected birds being annihilated daily. There are also unofficial HPAI maps and flu shots that are supposedly “essential” to protect people against bird flu. And, of course, there is talk of new vaccines. There is also a recent article titled “U.S. Response to Avian Influenza, Echoes of COVID-19.”
“Despite having a pandemic playbook in early 2020, the U.S. appeared flat-footed in its response to COVID-19, including inadequate testing and unavailable personal protective equipment. And throughout the pandemic, mixed messaging on masks and later vaccines set back public health efforts,” said…
As H5N1 circulates, lessons from COVID-19 remain apparently unlearned. Once again, missteps that hurt the response to COVID-19 are being made regarding testing, surveillance, transparency, failure of communication, and lack of coordination throughout the healthcare system.
“The World Health Organization considers the virus a public health concern because of its potential to cause a pandemic,” according to NPR.
Why Were H7N9 Therapeutics Recently Put Under EUA?
H7N9 was the predominant strain in China, and seemingly many died.
According to John Cullen, “The outbreak of COVID-19 in 2020 is reminiscent of the H7N9 outbreak in 2013, which poses a HUGE threat to human health. The proportion of fatal cases of H7N9 receiving antibiotics, antiviral drugs, and oxygen treatment was higher than that of COVID-19.”
The surveillance continued for years.
And why would they remove the testing for H7N9 in January 2020?
H7N9 influenza was identified as a top health security concern before the National Security Council was disbanded in May 2018. Rear Admiral Luciana Borio, the NSC’s medical and biodefense preparedness director, stated in 2018 that “the threat of pandemic flu is the number one health security concern.”
Public health officials and lawmakers criticized the unit’s elimination, warning that it would leave the human population vulnerable to pandemic potential. In a letter to John Bolton, Congressman Ami Bera (D-CA) and others expressed their deep concerns about the White House’s recent actions to downgrade the importance of global health security.
It’s worth noting that while the NSC’s pandemic unit was disbanded, other agencies, such as the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC), continued to work on pandemic preparedness and response.
In mid-2018, Fauci told Congress, “When you have a respiratory virus that droplets and aerosol can spread and…there’s a degree of morbidity associated with that, you can have a catastrophe…The one that we always talk about is the 1918 pandemic, which killed between 50 and 100 million people…Influenza first, or something like influenza, is the one that keeps me up at night.”
At the time when he said that, the White House was tracking an outbreak of H7N9 virus, a new strain of the avian bird flu emerging in China.
The reorganization of the NSC under Bolton and what exactly happened to the pandemic response team have been under scrutiny. Competing narratives and disputes emerged around the restructuring and streamlining of the National Security Council in the Trump era, specifically regarding whether Bolton dismantled an office focused on pandemics.
Fast forward to July 2024. Why did the HHS Secretary amend section 564(b)(1)of the Federal Food, Drug, and Cosmetic Act to include influenza A viruses with pandemic potential?
“This amendment to the 2013 determination is being done as a part of HHS’ preparedness efforts, and no changes have been made in the avian flu public health risk determination,” according to the McCullough Foundation.
On April 19, 2013, according to section 564(b)(1)(C) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), former Secretary Sebelius determined that there is a significant potential for a public health emergency involving the avian influenza A (H7N9) virus to affect national security or the health and security of United States citizens living abroad.
On July 18, 2024, HHS Secretary Xavier Becerra wrote:
“I amend April 19, 2013, determination of a significant potential for a public health emergency involving the avian influenza A (H7N9) virus, according to section 564(b)(1)(C) of the FD&C Act, and at this moment determines that there is a significant potential for a public health emergency that has a considerable potential to affect national security or the health and security of United States citizens living abroad and that involves biological agents, namely pandemic influenza A viruses and influenza A viruses with pandemic potential. Because H7N9 is an influenza A virus with pandemic potential, the declaration issued on April 19, 2013, under section 564(b)(1) of the FD&C Act, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection of avian influenza A (H7N9) virus, and that is based on April 19, 2013, determination, remains in effect until that declaration is terminated by section 564 of the FD&C Act.” (Bold was added for emphasis by the author).
SAM Vaccines, Nanotech, And H7N9
Barely anyone talks about the nanoforming happening on our planet as part of the transhumanist agenda. They are going after the very vital elements that make us human: our blood, breath, and heart. The global elitists want to meld man with machines.
The Self-Assembling mRNA (SAM®) vaccine against H7N9 influenza is immunogenic in mice. They are using an enzymatic, cell-free gene assembly technique to synthesize hemagglutinin (HA) and neuraminidase (NA) genes and their use to generate synthetic vaccine seeds in less than a week from discovering a new virus.
Of the new approaches, nucleic acid (plasmid DNA and mRNA) offers the most significant potential for speed. Similarly, testing of non-amplifying mRNA in preclinical animal models (mice, ferrets, and pigs) has indicated that two doses (80–250 µg) of vaccine are required to elicit protective responses. We have previously described the SAM vaccine platform.
This platform is based on a synthetic, self-amplifying mRNA delivered by a synthetic lipid nanoparticle (LNP). The combination of gene synthesis and the SAM vaccine technology could enable unprecedented speed and reliability of future vaccine responses to influenza pandemics.
The NIH paper demonstrates that a SAM vaccine encoding an influenza H1 HA antigen from the H1N1 virus was immunogenic in mice at low doses, eliciting antibody responses comparable to a licensed influenza vaccine. In addition, when they used the gene assembly and error correction technique for the rapid and accurate cell-free synthesis of the HA gene, they generated a SAM vaccine encoding an influenza H7 HA antigen from the H7N9 virus. The “vaccine” was ready for immunization eight days after the availability of the H7 gene sequence and 35 days after vaccination elicited mouse antibody titers associated with protecting humans from influenza.
Researchers say combining gene synthesis and SAM vaccine technology could enable unprecedented speed and reliability of future vaccine responses to influenza pandemics.
They gauge that the combination of gene synthesis and the SAM vaccine technology could enable unprecedented speed and reliability of future vaccine responses to influenza pandemics.
Common Symptoms of the H7N9 Virus Infection:
H7N9 is a subtype of the avian influenza virus (bird flu) that can infect humans. Symptoms of H7N9 infection are similar to other flu-like illnesses but can range from mild to severe. They include:
- Fever
- Cough
- Sore throat
- Muscle aches (myalgia)
- Fatigue
- Headache
- Runny or stuffy nose
- Severe Symptoms:
- Difficulty breathing or shortness of breath (indicating pneumonia or other respiratory complications)
- Chest pain
- High fever
- Respiratory distress syndrome (severe difficulty breathing)
- Diarrhea (in some cases)
- Organ failure (in severe cases)
Complications:
According to articles on Google Scholar, H7N9 is a respiratory disease that can lead to more severe complications like pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure, and sepsis, especially in high-risk populations like the elderly or those with chronic illnesses.
The infection can often progress rapidly from mild flu-like symptoms to severe respiratory illness requiring hospitalization. If you suspect exposure to H7N9, seeking medical care promptly is essential, as early antiviral treatment can help reduce severity.
Fact Sheets outline that antiviral medications are available and can effectively treat H7N9 infections if administered early. The most commonly used antivirals for H7N9 are neuraminidase inhibitors, also used to treat seasonal influenza. These antivirals help to reduce the virus’s ability to spread within the body and can lessen the severity of symptoms if taken soon after symptoms appear. John Cullen outlines a few in our interview. Some strains of H7N9 have shown resistance to specific antivirals, so ongoing monitoring and testing are crucial to determine the best course of treatment. At HoneyColony, we prefer using Silver Excelsior or investing in a machine to make colloidal silver at home.
Be sure to also read Maryam’s July 2024 article Bird Flu GOF in Plain Sight here at The Tenpenny Report.
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Like what you’re reading on The Tenpenny Report? Share this article with your friends. Help us grow.
Get more of Dr. Tenpenny’s voice of reason at her website.
Join our list here
Make a donation here (and thank you!)
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Maryam Henein is an investigative journalist, and founder, and editor-in-chief of the health magazine and marketplace HoneyColony. Read her Substack here. She is also a functional medicine consultant/coach, and the director of the award-winning documentary film Vanishing of the Bees, narrated by Elliot Page. Follow her on Twitter @maryamhenein. Email her: maryam@honeycolony.com.